Paramount Peptides
Finnrick has tested 65 samples from Paramount Peptides across 8 products.
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Ipamorelin | 7 | 27 Feb 2025 | 5 May 2025 | |||||
| PT-141 | 3 | 25 Apr 2025 | 7 May 2025 | |||||
| Retatrutide | 12 | 14 Jan 2025 | 6 Dec 2025 | |||||
| Semaglutide | 9 | 14 Jan 2025 | 6 May 2025 | |||||
| Survodutide | 3 | 25 Apr 2025 | 6 May 2025 | |||||
| BPC-157 | 11 | 14 Jan 2025 | 3 Oct 2025 | |||||
| Tirzepatide | 11 | 14 Jan 2025 | 2 Feb 2026 | |||||
| CJC-1295 | 9 | 14 Jan 2025 | 20 May 2025 | |||||
The Paramount Peptides samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Most recent Paramount Peptides tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 2 Feb 2026 | Tirzepatide | View | 20mg | 22.1mg | +10.5% | 99.08% | 01/2026 | White Label / Copper Crimp / Clear Cap | Lab E | Public | |
| 6 Dec 2025 | Retatrutide | View | 20mg | 20.5mg | +2.5% | 99.95% | (no batch ID) | White Label / Gold Crimp / Clear Cap | Lab E | Public | |
| 6 Dec 2025 | Retatrutide | View | 5mg | 5.07mg | +1.4% | 99.67% | (no batch ID) | White Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 6 Dec 2025 | Retatrutide | View | 10mg | 10.4mg | +4.0% | 99.95% | (no batch ID) | White Label / Silver Crimp / Red Cap | Lab E | Public | |
| 3 Oct 2025 | BPC-157 | View | 5mg | 4.92mg | -1.6% | 99.95% | (no batch ID) | No Label / Silver Crimp / White Cap | Lab E | Public | |
| 16 Jul 2025 | Tirzepatide | View | 5mg | 5.47mg | +9.4% | 99.83% | (no batch ID) | No Label / Silver Crimp / White Cap | Lab E | Public | |
| 10 Jul 2025 | BPC-157 | View | 5mg | 5.17mg | +3.4% | 98.57% | (no batch ID) | No Label / Silver Crimp / Yellow Cap | Lab A | Public | |
About Paramount Peptides Test Results From Finnrick
Paramount Peptides is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 8 products and 65 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud). Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
Paramount Peptides Testing Activity & Score Summary
In the past 30 days, Finnrick has published no new test results for Paramount Peptides. The overall dataset includes 65 tested samples with an average score of 6.7/10 across all products.
Across 65 identity-tested samples, 100% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.7%. Approximately 97% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products (top 2):
- Retatrutide (12 tests, 100% identity pass, median purity 99.9%) — Test scores are highly variable, ranging from 4.3 to 9.3 (average 7.5/10), suggesting significant batch-to-batch differences.
- Tirzepatide (11 tests, 100% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 3.6 to 8.9 (average 6.8/10), suggesting significant batch-to-batch differences.